NAS:CNCR
Range Cancer Therapeutics ETF | |
$ 14.5 -0.0247 ( -0.17%) 02:51 PM EST | |
PE Ratio:
20.97
PB Ratio:
2.07
Volume:
2.51K
Dividend Yield %:
0
| |
Last Holding update 2024-04-30 | 80 Stocks (1 new) |
Value $19.00 Mil | Turnover 18 % |
Portfolio Report | |
Registrant: Range Cancer Therapeutics ETF
|
This section is for PremiumPlus
Membership subscribers only.
GuruFocus PremiumPlus
Membership  Backtesting
 13F, 13D/G of all institutional investors
 Aggregated portfolio of any combinations among them
 FilingWiz
 Excel Add-In unlimited queries
 API (20,000 queries/month)
Â
And More